[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334420-105":59,"doc-detail-334420-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinicopathological-significance-of-c-met-and-her2-altered-expression-in-bladder-cancer","Clinicopathological significance of c-MET and HER2 altered expression in bladder cancer","","Tumor recurrence or metastasis after surgery strongly shapes bladder cancer prognosis, yet current biomarkers provide limited predictive power for individual outcomes. This study investigated c‑MET and HER2 expression status in human bladder cancer and assessed their clinical significance for disease outcomes. Quantitative real‑time RT‑PCR was applied to 40 primary bladder cancer patients and 20 benign controls to evaluate expression levels and associations with clinicopathological features.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-significance-of-c-met-and-her2-altered-expression-in-bladder-cancer/334420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-significance-of-c-met-and-her2-altered-expression-in-bladder-cancer/334420.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are c-MET and HER2 important biomarkers in bladder cancer prognosis?","Question",{"text":112,"@type":113},"Tumor recurrence or metastasis after surgery drives prognosis, and current biomarkers are limited. c‑MET and HER2 are receptor tyrosine kinases whose altered expression may relate to aggressiveness and clinical outcomes in bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was c-MET and HER2 expression measured in the study?",{"text":117,"@type":113},"Expression levels were assessed using quantitative real-time polymerase chain reaction (RT‑PCR) on 40 bladder cancer patients and 20 benign disease controls.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical features were associated with altered c-MET and HER2 expression?",{"text":121,"@type":113},"c‑MET overexpression was linked with pathological stage, tumor grade, muscle invasion, and node involvement, while HER2 overexpression was linked with pathological stage, muscle invasion, and node involvement. Patients expressing both had the poorest disease-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334420,1790248914,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Naguib et al.  \nJournal of the Egyptian National Cancer Institute (2024) 36:42  \n[https://doi.org/10.1186/s43046-024-00250-2](https://doi.org/10.1186/s43046-024-00250-2)  \nJournal of the Egyptian National Cancer Institute  \n RESEARCH Open Access  \nClinicopathological significance of c-MET  \nand HER2 altered expression in bladder cancer  \nEngy Mohammed Naguib 1* , EF Ismail 1, DI Badran 1, MH Sherief2 and TB El‑Abaseri 1  \nAbstract  \nBackground Tumor recurrence or metastasis after surgery is a significant factor influencing bladder cancer (BC) prognosis. Novel molecular biomarkers are necessary to determine each patient’s specific outcome because current biomarkers have limited power for predicting prognosis. The proto‑oncogene MET encodes c‑MET, a tyrosine kinase receptor. When c‑MET attaches to its ligand, it triggers several steps in the signal transduction cascade that control cell survival, proliferation, and invasion. c-MET is overexpressed in several carcinomas. The HER2 gene encodes another receptor tyrosine kinase (RTK) . HER2 overexpression is linked to altered proliferation and increased aggressiveness in several malignancies. Identifying crosstalk partners of RTKs implicated in bladder cancer development may have a unique role in predicting aggressiveness. This study explored the expression status of c‑MET and HER2 in human BC and their clinical significance in disease outcomes.  \nMethods A quantitative real‑time polymerase chain reaction was done on 40 BC patients who had undergone transurethral resection (TUR) or radical cystectomy and had a pathologically verified diagnosis of primary tumor with‑ out prior chemoradiotherapy as well as 20 patients with benign diseases who served as controls. The c‑MET and HER2 expression levels were investigated, and their relationship with clinicopathological features was analyzed.  \nResults c-MET and HER2 gene expression were significantly higher, 6.1‑ and 4.5‑fold, in the study group compared to the controls. The frequency of c‑MET and HER2 overexpression in the study group was 80%(32/40) and 90%(36/40), respectively. c-MET overexpression was associated with pathological stage(P = 0 . 002), tumor grade (P = 0 . 019), muscle invasion (P = 0 . 008), and node involvement (P = 0 . 017), while HER2 overexpression was associated with patho‑ logical stage(P = 0 . 033), invasion to muscles (P = 0 . 003), and node involvement (P = 0 . 005) . Based on the Log‑rank test, patients expressing both c-MET and HER2 had the poorest disease‑free survival rates among all studied patients (median = 10 m, 3 .0–16. 9 95%CI) .  \nConclusion There is a possible correlation between c‑MET and HER2 gene overexpression and poor clinical out‑ comes in patients with BC.  \nKeywords Bladder cancer, RT‑PCR, c-MET, HER2, Gene expression  \n*Correspondence:  \nEngy Mohammed Naguib [engynaguib@med.suez.edu.eg](engynaguib@med.suez.edu.eg)  \n1 Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt  \n2 Urology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt  \nIntroduction  \nBladder cancer (BC) ranks as the 6th most common cancer in men and the 17th most common in women globally. In Egypt, BC is the 3rd most frequent malignancy, following liver and breast cancer [1]. Urothelial carcinoma is the most common type of BC, comprising around 90% of cases in industrialized countries and 80% in other parts of the world. Among the many diverse BC subtypes, the common non-muscle invasive bladder cancer (NMIBC) is linked to a promising prognosis.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third","cbCaimdwPhyWfflo","https://ap.wps.com/l/cbCaimdwPhyWfflo","pdf",1121094,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"Why are c-MET and HER2 important biomarkers in bladder cancer prognosis?\",\"answer\":\"Tumor recurrence or metastasis after surgery drives prognosis, and current biomarkers are limited. c‑MET and HER2 are receptor tyrosine kinases whose altered expression may relate to aggressiveness and clinical outcomes in bladder cancer.\"},{\"question\":\"How was c-MET and HER2 expression measured in the study?\",\"answer\":\"Expression levels were assessed using quantitative real-time polymerase chain reaction (RT‑PCR) on 40 bladder cancer patients and 20 benign disease controls.\"},{\"question\":\"What clinical features were associated with altered c-MET and HER2 expression?\",\"answer\":\"c‑MET overexpression was linked with pathological stage, tumor grade, muscle invasion, and node involvement, while HER2 overexpression was linked with pathological stage, muscle invasion, and node involvement. Patients expressing both had the poorest disease-free survival.\"}]","Clinicopathological significance of c-MET and HER2 altered expression in bladder cancer | PDF",1790006546,23]